Publication hold · product and protocol verification
Skin Booster in Seoul
This page is retained to explain product identity, evidence limits, and questions to verify before planning. It does not confirm clinic availability, variants, a protocol, a price, or an outcome timeline.
Board-Certified Dermatologist
Dr. SangYoul Yun
AAD International Fellow
IFAAD
- Duration
- Set after assessment
- Sessions
- No universal course
- Downtime
- Varies by plan
Skin Booster Overview
PN and PDRN are not interchangeable evidence categories. Findings about adenosine A2A signaling or nucleotide salvage reported for PDRN cannot automatically be transferred to PN or a Rejuran product. Product-specific clinic details remain unpublished pending operator and physician confirmation.
Best for
- Product identity and evidence limits
- Questions to verify before treatment planning
Suited for
- People seeking a product- and route-specific review before deciding whether to proceed
- Duration
Set after assessment
- Sessions
No universal course
- Downtime
Varies by plan
- Peak result
Reassessed over time
How Skin Booster Works
1
First verify the exact product, indication, route, and supporting records.
2
Only then discuss an individualized plan, alternatives, risks, recovery, and cost.
1
First verify the exact product, indication, route, and supporting records.
2
Only then discuss an individualized plan, alternatives, risks, recovery, and cost.
Treatment explained
Skin Booster: an illustrative injection into the cheek dermis
An illustrative film: the actual product, injection route and dose may differ after consultation.
Film guide (1–9)
What the numbers show
- 1. Cheek · example injection area
- 2. Injection point on the cheek
- 3. Fine needle
- 4. Epidermis
- 5. Dermis
- 6. Subcutaneous fat
- 7. Muscle layer
- 8. Injection site
- 9. Injection site in the dermis
In the film
- In this example, a skin booster is injected at several points in the cheek's dermis.
- A fine needle enters the skin.
- The needle tip sits in the dermis.
- The injection is given at each point.
“Injectables and energy devices are performed by physicians, never delegated to non-physician staff. The clinic is led by a board-certified dermatologist.”
Skin Booster Before & After
Cases shown are Fitzpatrick III–IV (East Asian skin). Results in lighter (I–II) or darker (V–VI) skin types may differ, which is discussed at consultation.
FAQ
No. Findings about adenosine A2A signaling or nucleotide salvage reported for PDRN cannot automatically be transferred to PN or a Rejuran product. Product identity and product-specific human evidence must be assessed separately.
No. Exact variants, clinic availability, prices, dose, route, intervals, course, peak timing, durability, and maintenance remain unpublished until the operator and physician approve the supporting records.
The absence of an event in a small study cannot exclude uncommon or serious complications. A safety discussion must match the exact product, route, anatomy, protocol, alternatives, and consent information.
Session summary & comparison
| Item | Details |
|---|---|
| Duration | Set after assessment |
| Sessions | No universal course |
| Downtime | Varies by plan |
| Peak result | Reassessed over time |
For your visit
- Do not plan travel around a fixed recovery or result timeline until the exact product and proposed plan are confirmed.
Related procedures
Evidence & comparison guides
Need another answer before deciding?
You do not need to read every guide. Open the question that still matters to your decision.
Optional decision guides
- Comparison guideSculptra vs Skin Boosters Seoul | Evidence-Based GuideCompare Sculptra with Rejuran PN, Skinvive and Profhilo by treatment goal, published evidence, U.S. FDA status and practical questions to ask in Seoul.
- Comparison guideDermatology Downtime Guide Seoul | Recovery TimelinesRecovery timelines for Ultherapy, Thermage, fillers, lasers, and more in Seoul. Published clinical data, combination spacing, and flight-timing advice.
Clinic articles
- Clinic articleIs Rejuran PN or PDRN? Evidence, FDA Status & Seoul GuideIs Rejuran FDA approved? Our 2026 search found no U.S. FDA authorization. What PN vs PDRN means, the published evidence, risks, and what to ask in Seoul.
- Clinic articleSculptra Master, Thermage TTT & Rejuran VIP CertificationsLearn about our dermatologist's Sculptra Master, Thermage TTT Master, and Rejuran Club VIP designations, their issuing organizations, and what they mean.
- Clinic articleWhy Hand Technique Decides Your Injectable Outcome (2026 Review)Why hand technique decides your injectable outcome: a 2026 dermatologist's evidence review of cannula vs. needle, dose-response, and intradermal placement.
- Clinic articleJUVELOOK vs Rejuran: Evidence and Where Exosomes FitCompare JUVELOOK PDLLA-HA, Rejuran PN and topical exosome adjuncts by ingredient, evidence, risks and treatment route before booking in Seoul.
Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.
Next Step